640 related articles for article (PubMed ID: 27014638)
21. Activation of Shigella flexneri type 3 secretion requires a host-induced conformational change to the translocon pore.
Russo BC; Duncan JK; Wiscovitch AL; Hachey AC; Goldberg MB
PLoS Pathog; 2019 Nov; 15(11):e1007928. PubMed ID: 31725799
[TBL] [Abstract][Full Text] [Related]
22. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
[TBL] [Abstract][Full Text] [Related]
23. High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway.
Ernst NH; Reeves AZ; Ramseyer JE; Lesser CF
mBio; 2018 Jun; 9(3):. PubMed ID: 29921672
[TBL] [Abstract][Full Text] [Related]
24. Molecular bases of epithelial cell invasion by Shigella flexneri.
Sansonetti PJ; Egile C
Antonie Van Leeuwenhoek; 1998 Nov; 74(4):191-7. PubMed ID: 10081579
[TBL] [Abstract][Full Text] [Related]
25. The type three secretion system effector protein IpgB1 promotes Shigella flexneri cell-to-cell spread through double-membrane vacuole escape.
Weddle EA; Köseoğlu VK; DeVasure BA; Agaisse HF
PLoS Pathog; 2022 Feb; 18(2):e1010380. PubMed ID: 35202448
[TBL] [Abstract][Full Text] [Related]
26. The Shigella flexneri type 3 secretion system is required for tyrosine kinase-dependent protrusion resolution, and vacuole escape during bacterial dissemination.
Kuehl CJ; Dragoi AM; Agaisse H
PLoS One; 2014; 9(11):e112738. PubMed ID: 25405985
[TBL] [Abstract][Full Text] [Related]
27. Shigella infection of intestinal epithelium and circumvention of the host innate defense system.
Ashida H; Ogawa M; Mimuro H; Sasakawa C
Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985
[TBL] [Abstract][Full Text] [Related]
28. How Do the Virulence Factors of
Mattock E; Blocker AJ
Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
[No Abstract] [Full Text] [Related]
29. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes.
Killackey SA; Sorbara MT; Girardin SE
Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460
[TBL] [Abstract][Full Text] [Related]
30.
Watson JL; Sanchez-Garrido J; Goddard PJ; Torraca V; Mostowy S; Shenoy AR; Clements A
mBio; 2019 Dec; 10(6):. PubMed ID: 31848280
[TBL] [Abstract][Full Text] [Related]
31. Functional insights into the Shigella type III needle tip IpaD in secretion control and cell contact.
Schiavolin L; Meghraoui A; Cherradi Y; Biskri L; Botteaux A; Allaoui A
Mol Microbiol; 2013 Apr; 88(2):268-82. PubMed ID: 23421804
[TBL] [Abstract][Full Text] [Related]
32. Tracking the dynamic interplay between bacterial and host factors during pathogen-induced vacuole rupture in real time.
Ray K; Bobard A; Danckaert A; Paz-Haftel I; Clair C; Ehsani S; Tang C; Sansonetti P; Tran GV; Enninga J
Cell Microbiol; 2010 Apr; 12(4):545-56. PubMed ID: 20070313
[TBL] [Abstract][Full Text] [Related]
33. Formate Promotes
Koestler BJ; Fisher CR; Payne SM
mBio; 2018 Sep; 9(5):. PubMed ID: 30254126
[TBL] [Abstract][Full Text] [Related]
34. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.
D'Hauteville H; Khan S; Maskell DJ; Kussak A; Weintraub A; Mathison J; Ulevitch RJ; Wuscher N; Parsot C; Sansonetti PJ
J Immunol; 2002 May; 168(10):5240-51. PubMed ID: 11994481
[TBL] [Abstract][Full Text] [Related]
35. Shigella flexneri regulation of ARF6 activation during bacterial entry via an IpgD-mediated positive feedback loop.
Garza-Mayers AC; Miller KA; Russo BC; Nagda DV; Goldberg MB
mBio; 2015 Mar; 6(2):e02584. PubMed ID: 25736891
[TBL] [Abstract][Full Text] [Related]
36. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen.
Lucchini S; Liu H; Jin Q; Hinton JC; Yu J
Infect Immun; 2005 Jan; 73(1):88-102. PubMed ID: 15618144
[TBL] [Abstract][Full Text] [Related]
38. Spa47 is an oligomerization-activated type three secretion system (T3SS) ATPase from Shigella flexneri.
Burgess JL; Jones HB; Kumar P; Toth RT; Middaugh CR; Antony E; Dickenson NE
Protein Sci; 2016 May; 25(5):1037-48. PubMed ID: 26947936
[TBL] [Abstract][Full Text] [Related]
39. Shigella flexneri subverts host polarized exocytosis to enhance cell-to-cell spread.
Herath TUB; Roy A; Gianfelice A; Ireton K
Mol Microbiol; 2021 Nov; 116(5):1328-1346. PubMed ID: 34608697
[TBL] [Abstract][Full Text] [Related]
40. Hierarchies of host factor dynamics at the entry site of Shigella flexneri during host cell invasion.
Ehsani S; Santos JC; Rodrigues CD; Henriques R; Audry L; Zimmer C; Sansonetti P; Tran Van Nhieu G; Enninga J
Infect Immun; 2012 Jul; 80(7):2548-57. PubMed ID: 22526677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
